Stimulant Laxative Tablet, Sugar Coated
NDC Package 51316-734-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Stimulant Laxative (sennosides) tablets is sennosides are used to treat constipation. This formulation utilizes a tablet, sugar coated delivery system. Marketed by Cvs Woonsocket Prescription Center, Incorporated, this product is identified by NDC 51316-734 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
51316-734-01
Package Description
2 BLISTER PACK in 1 CARTON / 15 TABLET, SUGAR COATED in 1 BLISTER PACK
Product Code
51316-734
11-Digit Billing Format
51316073401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Stimulant Laxative
Non-Proprietary Name
Sennosides
Substance Name
Sennosides
Dosage Form
Tablet, Sugar Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES 15 mg/1
Usage Information
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

Regulatory & Marketing

Labeler Name
Cvs Woonsocket Prescription Center, Incorporated
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-08-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51316-734-01 identifies a specific commercial package of 2 blister pack in 1 carton / 15 tablet, sugar coated in 1 blister pack of Stimulant Laxative, a human over the counter drug labeled by Cvs Woonsocket Prescription Center, Incorporated. This tablet, sugar coated is formulated for oral use and contains sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Woonsocket Prescription Center, Incorporated on May 08, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

How is this Cvs Woonsocket Prescription Center, Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51316073401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51316-734-01
11-Digit CMS (5-4-2)
51316-0734-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.